1 Min Read
* Mylan launches generic Cancidasfor injection
* Mylan received final approval from U.S. FDA for its Abbreviated New Drug Application for this antifungal which has multiple indications Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.